Molecular detection of Human Papillomavirus genotype-16&-18 in tissues from patients with prostate cancer and benign prostatic hyperplasia

Background: High oncogenic-risk genotypes of human Papillomavirus (HPV) infect a wide range of human cells, including prostate tissue that give rise to benign prostatic hyperplasia and prostatic adenocarcinomas. Objectives: This study aimed to detect DNA of HPV genotype-16 &18 using in situ hybridization technique in prostatic tissues from benign prostatic hyperplasia and prostatic adenocarcinomas, and elucidate the association between these HPV genotypes and prostatic carcinogenesis. Patients and methods: Forty-eight (48) formalin-fixed, paraffin embedded prostatic tissue blocks were obtained ,among them (28) tissue biopsies from prostatic carcinoma with different grades and (20) benign prostate hyperplastic tissue blocks as well as (10) apparently normal prostate tissue autopsies which were collected from the archives of Forensic Medicine Institute / Baghdad and used as prostate healthy control groups. Detection and genotyping of HPV was done by highly sensitive in situ hybridization technique. Results: The signals of in situ hybridization reactions of both HPV-16 and HPV-18 in prostate cancer cases in the present study was 25% (7 / 28) whereas in BPH, HPV-16 was detected in 45 %( 9 /20) and HPV-18 was presented in 35 %( 7/ 20). Neither HPV-16 nor HPV-18 was detected in the apparently healthy control group.The percentages of HPV 16 and HPV18 were increasing with advancing of grade of prostate cancer. Conclusion: Our results indicate that the oncogenic HPV-16 might contribute to the development of subset of prostate tumors. In addition, HPV16&18 might have a crucial role in progression of the prostate cancer and benign prostatic hyperplasi

Evaluation of antibacterial activity and flavonoid content of two capparis species from Iran

Background: Due to multiple drug resistance against antimicrobial drugs for treatment of infectious disease, investigations to discovering new antibacterial compounds from natural sources have been designated. Objective: According to antimicrobial effects of some Capparis species, this study was carried out to evaluate the antimicrobial activity of the extract and fractions of Capparis cartilaginea and Capparis mucronifolia against 6 bacterial strains. Methods: Aerial parts of the Capparis species were extracted by maceration method using methanol and fractionated separately by liquid-liquid fractionation method. The antibacterial activity of the extract and fractions were studied against 6 bacterial strains using MIC microplate method. Total flavonoid content (TFC) of the extracts and fractions was determined using AlCl3 reagent. Results: The total extract and methanolic fractions of C. mucronifolia were the most effective fractions against the bacterial strains. Methanolic fraction of C. cartilaginea was the most effective fraction with MIC 10.42 μg/ml against Salmonella enterica. The highest antibacterial activity of C.mucronifolia was against Staphylococcus epidermidis with MIC 7.8 μg/ml. Methanolic fractions of Capparis species showed the highest TFC value in AlCl3 colorimetric assay. Conclusion: The results of this study indicate that the extracts and fractions of Capparis cartilaginea and Capparis mucronifolia have antimicrobial effect against 6 gram positive and gram negative strains. According to the high amount of flavonoids in methanolic fraction of C. mucronifolia, the antibacterial activity may be related to the flavonoid compounds of this plant